Evidence map›Paper›PMID 32252754›Full record

ArticleBMC medical genomics2020

E. coli diversity: low in colorectal cancer.

Le Tang, Yu-Jie Zhou, Songling Zhu, Gong-Da Liang, He Zhuang, Man-Fei Zhao, Xiao-Yun Chang, Hai-Ning Li, Zheng Liu, Zhi-Rong Guo and 16 more

Abstract read
In one paragraph

Article in BMC medical genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Microbiology spectrum · 2025
    Article
  4. Review
  5. Article
  6. GutWomen's health reports (New Rochelle, N.Y.) · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Le TangSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Yu-Jie ZhouSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Songling ZhuSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Gong-Da LiangSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
He ZhuangSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Man-Fei ZhaoSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Xiao-Yun ChangSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Hai-Ning LiSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Zheng LiuDepartment of Colorectal Surgery of the Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Zhi-Rong GuoDepartment of Microbiology, Peking University Health Sciences Center, Beijing, China.
Wei-Qiao LiuMicrobiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Canada.
Xiaoyan HeDepartment of Microbiology, Peking University Health Sciences Center, Beijing, China.
Chun-Xiao WangSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Dan-Dan ZhaoSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Jia-Jing LiSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Xiao-Qin MuSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Bing-Qing YaoSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Xia LiSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
Yong-Guo LiDepartment of Infectious Diseases of the First Affiliated Hospital, Harbin Medical University, Harbin, China.
Li-Bo DuoClinical Laboratory of Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Li WangClinical Laboratory of Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Randal N JohnstonBiochemistry and Molecular Biology, University of Calgary, Calgary, Canada.
Jin ZhouDepartment of Hematology of the First Affiliated Hospital, Harbin Medical University, Harbin, China.
Jing-Bo ZhaoDepartment of Epidemiology, Public Health School, Harbin Medical University, Harbin, China.
Gui-Rong LiuSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China. grliu@hrbmu.edu.cn.
Shu-Lin LiuSystemomics Center, College of Pharmacy, and Genomics Research Center (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, 157 Baojian Road, Harbin, 150081, China. slliu@hrbmu.edu.cn.

Funding

Heilongjiang Innovation Endowment Award for graduate studies YJSCX2012-214HLJNational Natural Science Foundation of China NSFC30970078National Natural Science Foundation of China NSFC31600001National Natural Science Foundation of China NSFC81030029National Natural Science Foundation of China NSFC81271786National Natural Science Foundation of China NSFC81671980National Natural Science Foundation of China NSFC81871623National Natural Science Foundation of China NSFC81971910National Postdoctoral Fellowship of China 2016M600266
6 · The paper itself

Abstract

backgroundEscherichia coli are mostly commensals but also contain pathogenic lineages. It is largely unclear whether the commensal E. coli as the potential origins of pathogenic lineages may consist of monophyletic or polyphyletic populations, elucidation of which is expected to lead to novel insights into the associations of E. coli diversity with human health and diseases.

methodsUsing genomic sequencing and pulsed field gel electrophoresis (PFGE) techniques, we analyzed E. coli from the intestinal microbiota of three groups of healthy individuals, including preschool children, university students, and seniors of a longevity village, as well as colorectal cancer (CRC) patients, to probe the commensal E. coli populations for their diversity.

resultsWe delineated the 2280 fresh E. coli isolates from 185 subjects into distinct genome types (genotypes) by PFGE. The genomic diversity of the sampled E. coli populations was so high that a given subject may have multiple genotypes of E. coli, with the general diversity within a host going up from preschool children through university students to seniors. Compared to the healthy subjects, the CRC patients had the lowest diversity level among their E. coli isolates. Notably, E. coli isolates from CRC patients could suppress the growth of E. coli bacteria isolated from healthy controls under nutrient-limited culture conditions.

conclusionsThe coexistence of multiple E. coli lineages in a host may help create and maintain a microbial environment that is beneficial to the host. As such, the low diversity of E. coli bacteria may be associated with unhealthy microenvironment in the intestine and hence facilitate the pathogenesis of diseases such as CRC.

Indexed as

Genetic VariationAdolescentAdultAgedChildChild, PreschoolChinaColorectal NeoplasmsDNA, BacterialEscherichia coliEscherichia coli InfectionsFemaleGenotypeHumansMaleMiddle AgedDNA, BacterialColorectal cancerEscherichia coliGenetic diversityIntestinal microbiotaLongevity

Identifiers

PMID32252754
PMCPMC7133007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.